Clinical-Pathologic Analysis of Breast Cancer With PIK3CA Mutations in Chinese Women

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• PIK3CA mutations are implicated in breast cancer development and progression.
• The prevalence of PIK3CA mutations in Chinese breast cancer populations may be underestimated.

Purpose of the Study:

• To determine the frequency and distribution of somatic PIK3CA mutations in Chinese breast cancer patients.
• To investigate the association between PIK3CA mutations and tumor phenotypes in this population.

Main Methods:

• Somatic mutational analysis of the PIK3CA gene was performed on 113 primary breast cancer samples from Chinese women.
• Amplification Refractory Mutation System (ARMS) was utilized for mutation detection.
• Clinicopathological characteristics were analyzed in relation to PIK3CA mutation status.

Main Results:

• PIK3CA gene mutations were identified in 43 (38.05%) of the cases, with a notable concentration in exons 9 and 20.
• No significant correlation was found between PIK3CA mutations and age, lymph node status, tumor grade, ER/PR status, or P53 expression.
• HER2 gene amplification showed no significant difference between PIK3CA-mutated and non-mutated groups.

Conclusions:

• A high frequency of somatic PIK3CA mutations exists in Chinese breast cancer patients, particularly in exon 20.
• The clinical and pathological significance of PIK3CA mutations requires further investigation in larger patient cohorts.
• PIK3CA mutations show potential as therapeutic targets and prognostic indicators in breast cancer.